Aquestive Therapeutics (traded under the ticker AQST) exhibits high levels of stock price volatility, a characteristic common among small-cap pharmaceutical and specialty drug development companies. Its equity valuation fluctuates dynamically in response to regulatory decisions by health authorities regarding its proprietary drug delivery platforms, clinical trial results, quarterly financial disclosures, and changing market sentiment surrounding specialty pharma companies striving to commercialize complex pharmaceutical assets.